Bergenstal, R. M., Forti, A., Chiasson, J., Woloschak, M., Boldrin, M., & Balena, R. (2012). Efficacy and Safety of Taspoglutide Versus Sitagliptin for Type 2 Diabetes Mellitus (T-Emerge 4 Trial). Springer Healthcare Communications.
Citação norma ChicagoBergenstal, Richard M., Adriana Forti, Jean-Louis Chiasson, Michael Woloschak, Mark Boldrin, and Raffaella Balena. Efficacy and Safety of Taspoglutide Versus Sitagliptin for Type 2 Diabetes Mellitus (T-Emerge 4 Trial). Springer Healthcare Communications, 2012.
Citação norma MLABergenstal, Richard M., et al. Efficacy and Safety of Taspoglutide Versus Sitagliptin for Type 2 Diabetes Mellitus (T-Emerge 4 Trial). Springer Healthcare Communications, 2012.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.